301 related articles for article (PubMed ID: 25802925)
1. Encouraging spontaneous reporting of adverse effects.
Prescrire Int; 2015 Feb; 24(157):53. PubMed ID: 25802925
[TBL] [Abstract][Full Text] [Related]
2. Pharmacovigilance in Europe.
Johnson CL; Hutchinson JA
Transplantation; 2015 Aug; 99(8):1542-3. PubMed ID: 26308299
[No Abstract] [Full Text] [Related]
3. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
4. [Direct reporting by patients of adverse drug reactions in Spain].
Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
[TBL] [Abstract][Full Text] [Related]
5. Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology.
Baldo P; Francescon S; Fornasier G
Int J Clin Pharm; 2018 Aug; 40(4):748-753. PubMed ID: 30094557
[TBL] [Abstract][Full Text] [Related]
6. Pharmacovigilance and use of online health information.
Masoni M; Guelfi MR; Conti A; Gensini GF
Trends Pharmacol Sci; 2013 Jul; 34(7):357-8. PubMed ID: 23759353
[No Abstract] [Full Text] [Related]
7. Fifty years of pharmacovigilance - Medicines safety and public health.
Laporte JR
Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):725-32. PubMed ID: 26799344
[No Abstract] [Full Text] [Related]
8. UMC's ground-breaking web tool brings patient safety into focus.
Int J Risk Saf Med; 2013; 25(3):193-5. PubMed ID: 24047690
[No Abstract] [Full Text] [Related]
9. Adverse drug reactions in neonates: could we be documenting more?
Hawcutt DB; O'Connor O; Turner MA
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):807-20. PubMed ID: 25225053
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
Schäublin M
Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
[TBL] [Abstract][Full Text] [Related]
11. Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance?
Bagheri H; Lacroix I; Guitton E; Damase-Michel C; Montastruc JL
Therapie; 2016 Apr; 71(2):235-9. PubMed ID: 27080844
[TBL] [Abstract][Full Text] [Related]
12. [Impact of a regional pharmacovigilance network on notification of adverse drug reactions: results at 3 years].
Picard S; Polard E; Oger E; Bellissant E
Therapie; 2015; 70(3):293-9. PubMed ID: 25534522
[TBL] [Abstract][Full Text] [Related]
13. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
Krähenbühl S
Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
[TBL] [Abstract][Full Text] [Related]
14. [From pharmacovigilance to pharmacoepidemiology and risk coordination].
Montastruc JL
Rev Med Interne; 2009 Dec; 30 Suppl 4():S281-90. PubMed ID: 19892443
[No Abstract] [Full Text] [Related]
15. Pharmacovigilance in Europe: Place of the Pharmacovigilance Risk Assessment Committee (PRAC) in organisation and decisional processes.
Laroche ML; Batz A; Géniaux H; Féchant C; Merle L; Maison P
Therapie; 2016 Apr; 71(2):161-9. PubMed ID: 27080834
[TBL] [Abstract][Full Text] [Related]
16. [Safety of medicinal products and reporting of adverse drug reactions].
Skibicka I; Maciejczyk A
Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
[TBL] [Abstract][Full Text] [Related]
17. French pharmacovigilance: Missions, organization and perspectives.
Vial T
Therapie; 2016 Apr; 71(2):143-50. PubMed ID: 27080832
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoepidemiology and its input to pharmacovigilance.
Faillie JL; Montastruc F; Montastruc JL; Pariente A
Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
[TBL] [Abstract][Full Text] [Related]
19. Pharmacovigilance: Importance, concepts, and processes.
Kumar A
Am J Health Syst Pharm; 2017 Apr; 74(8):606-612. PubMed ID: 28235869
[No Abstract] [Full Text] [Related]
20. Is pharmacovigilance of biologicals cost-effective?
Claus B
Int J Clin Pharm; 2018 Aug; 40(4):787-789. PubMed ID: 30051230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
